Aranesp 40 MCG/0.4 ML syringe 0.4ML
Ended Awarded
- Contract number
- SPE2DR26FT427
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $2,531
Award facts
- Contract value 100% obligated
- $2,531.43 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,531.43 on October 29, 2025, for the supply of Aranespâ„¢ 40 mcg/0.4 mL syringes. This is a firm fixed-price, competitively awarded contract with no set-aside designation, scheduled for completion by October 30, 2025. The work will be performed at AmerisourceBergen's Corporate Office facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 prime vendor agreement running through December 2026 that provides comprehensive pharmaceutical and medical supply support for military healthcare operations globally.
AmerisourceBergen Drug Corp, one of the nation's largest pharmaceutical distributors, serves as a critical vendor for federal medical procurement through its portfolio of competitively awarded contracts with the Defense Logistics Agency and Military Health System. The company supplies an extensive range of pharmaceutical products and medical supplies, including specialty medications, vaccines, and medical devices across multiple therapeutic domains. Aranespâ„¢ is an erythropoiesis-stimulating agent commonly used in military and federal healthcare settings to treat anemia. This delivery order reflects the company's ongoing role as a key supplier within DLA's pharmaceutical supply chain supporting Defense Health Agency and other federal healthcare systems.
Quick answers
Who was awarded contract SPE2DR26FT427?
SPE2DR26FT427 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 29, 2025.
How much is contract SPE2DR26FT427 worth?
The government has obligated $2,531 on SPE2DR26FT427.
Is contract SPE2DR26FT427 an order under another contract?
Yes. SPE2DR26FT427 is a delivery order under SPE2DR25D1053, an indefinite delivery contract.
Was contract SPE2DR26FT427 competed?
The extent of competition for SPE2DR26FT427 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award